Announce your event here
Third World Congress on Clinical Lipidology
2017-02-10 to 2017-02-12
Brisbane, Australia

An Asia Pacific economic powerhouse, Brisbane is fortified by robust industry and expert business and thought leaders, creating the ultimate setting for learning and business development opportunities.

World-class facilities, a subtropical climate and practical infrastructure make Brisbane the perfect host city for conferences, business meetings and major events.

As the closest Australian eastern seaboard capital city to Asia, Brisbane has unparalleled airport and port infrastructure and a range of conference venues, accommodation facilities and support services that can be tailored to suit conference delegations of all sizes.

http://clinical-lipidology.com/external link

The 7th International Conference on Fixed Combination Therapy in Cardiovascular Disease, Hypertension, Diabetes, Dyslipidemia and Cardio-Metabolic Syndrome
2017-03-02 to 2017-03-05
Cannes, France
Fixed combination has become popular over the recent years. It enables us to treat the patients with smaller amounts of tablets, thus improving compliance and effectiveness of treatment. It simplifies treatment, may decrease costs and minimizes the likelihood of missed doses. In specific cases it enables us to give lower doses of each component drug and thus combination therapy may reduce side effects. As a result, fixed combination therapy has shown to improve adherence and patients’ clinical outcomes.

http://2017.fixedcombination.com/external link

2017 Weinstein Cardiovascular Development Conference
2017-05-04 to 2017-05-06
Columbus, OH, USA
The Weinstein Cardiovascular Development Conference is an annual meeting for basic and clinical scientists investigating normal and abnormal development of the heart and vasculature as it may ultimately relate to human disease. It is a freestanding meeting unaffiliated with any society or parent organization. Interested individuals or groups from host institutions organize it on a rotating basis. The intent of the meeting is to advance the overall field of cardiovascular development and improve patient outcome through the sharing of information and the facilitation of collaborative investigations. True to the vision of Dr. Constance Weinstein, who first organized this conference, the meeting is intended to include as many perspectives as possible. Investigators in any relevant area that can provide contributions to our understanding of heart and vascular development are welcome to contribute.

http://www.nationwidechildrens.org/weinstein2017external link

ICCAD 2017 – the 12th International Congress on Innovations in CORONARY ARTERY DISEASE – from Prevention to Intervention
2017-10-15 to 2017-10-17
Venice, Italy

The scientific program of ICCAD 2017 is being planned with the collaboration and endorsement of the ESC Working Group for Cardiovascular Pharmacotherapy and other prestigious groups. Keynote lectures will be delivered by a distinguished international faculty, while a large number of selected free communications will report new data from basic research laboratories and clinical centers around the globe.

The ICCAD program will include sessions on basic research, stem cell research and myocardial repair, vascular biology and clinical cardiology. We will also dedicate sessions to new advances in pharmacotherapy, especially to the current challenges in antithrombotic and antiplatelet therapy and to the new drugs in lipidology and diabetes which may so dramatically change the outcome and improve the prognosis. We will also discuss the latest news in interventional cardiology, stents and strategies, including the challenge of concomitant carotid and peripheral vascular disease, the rapidly expanding field of valvular interventions, and the role of the heart team and surgical management of coronary and cardiovascular disease.

http://www.iccadcongress.com/external link